Johnson & Johnson (#JNJ) Stock Price, Live Chart & Analysis | Trade #JNJ
Johnson & Johnson is the world's leader in the public health and cosmetics sector. The company was founded in 1886 and is now headquartered in New Brunswick, New Jersey, United States. It operates in three business directions: consumers' health, the pharmaceutical industry, and medical equipment. Johnson & Johnson is associated with over 250 brands, including Johnson's, Aveeno, Acuvue, Listerine, Clean & Clear, and others.
The company's stock has grown stably since 2012. JNJ is also a component of the Dow Jones and S&P 500 indices.
When analyzing Johnson & Johnson's stock, pay attention to the company's business activity. New business openings, successful takeovers, and new product launches positively impact JNJ's value. Fundamental factors, such as the state of the global economy, political events, and epidemics, play an important role, too. Johnson & Johnson took part in developing the vaccine against COVID-19, which strengthened the company's position in the market and raised the cost of its stock.
It's also important to keep track of the company's news. Scandals and lawsuits have a negative effect on Johnson & Johnson's revenue and stock cost. For example, JNJ shares went down in 2018 as one of the company's products — baby powder — was alleged to cause cancer.
Also, it is a good practice to examine the competitors' activity — Pfizer, Sanofi, Merck&Co, and others. Their success can attract more investors, which will raise their profits. Johnson & Johnson's profit and stock rate will fall.
Risk warning: Trading in FX and CFDs entails high risk of losing capital.
Are you interested in buying Johnson & Johnson (#JNJ)? It’s easy!
SellBuyActive SellActive Buy
| Sell | 165.85 |
| Buy | 165.89 |
| Sentiment | 100% ▾ |
| 1-day change | 7.63(4.82%) |
Earn from the fluctuations of prices and boost your income with LiteFinance!
Johnson & Johnson (#JNJ) shares’ cost is $165.89 for today. The highest rate of shares Johnson & Johnson (#JNJ) for today is $165.9800, the lowest price is $163.8100. The opening price was $164.12.
A real-time chart for Johnson & Johnson (#JNJ) shares quote is provided below.
Price chart of #JNJ in real time mode
Available in trading accounts:
- ECN
- CLASSIC
Prev. Close164.23
Day's Range163.8100 - 165.9800
Opening164.12
52 wk Range143.13-165.98
Volume7,971,017
Shares Outstanding2,407,243,667
Average Volume7,010,009
Market Cap399.27B
1-Year Return3.35%
EPS15.6
Beta0.517
Revenue86.58B
P/E Ratio10.58
Dividends4.96(2.99%)
Next Earnings Date2024-10-15
Spread0
Swap Long-6
Contract size1
Swap Short2.5
Stop&Limit Level0
| #AA | N/A | N/A | -0.42 | -1.29% |
| #ABBV | N/A | N/A | 8.4 | 4.47% |
| #ABT | N/A | N/A | 6.45 | 6.04% |
| #ADM | N/A | N/A | -0.71 | -1.15% |
| #AMWL | N/A | N/A | -2.03 | -19.77% |
| #AXP | N/A | N/A | 6.6 | 2.62% |
| #BA | N/A | N/A | -11.02 | -5.98% |
| #BABA | N/A | N/A | 4.04 | 5.10% |
| #BAC | N/A | N/A | 1.1 | 2.77% |
| #BB | N/A | N/A | -0.07 | -2.90% |
| #CAT | N/A | N/A | 11.36 | 3.30% |
| #CLX | N/A | N/A | 27.22 | 20.76% |
| #COTY | N/A | N/A | -0.48 | -4.87% |
| #CVX | N/A | N/A | -8.8 | -5.62% |
| #DIS | N/A | N/A | -3.11 | -3.33% |
| #DVN | N/A | N/A | -1.68 | -3.61% |
| #EDU | N/A | N/A | -0.05 | -0.08% |
| #F | N/A | N/A | 0.34 | 3.13% |
| #FIS | N/A | N/A | 6.07 | 7.95% |
| #FTI | N/A | N/A | -2.65 | -8.99% |
| #GD | N/A | N/A | 3.23 | 1.09% |
| #GE | N/A | N/A | 0.56 | 0.32% |
| #GPN | N/A | N/A | 10.02 | 9.94% |
| #HD | N/A | N/A | 1.11 | 0.30% |
| #HPQ | N/A | N/A | 0.12 | 0.33% |
| #IBM | N/A | N/A | 10.16 | 5.29% |
| #JNJ | N/A | N/A | 7.63 | 4.82% |
| #JPM | N/A | N/A | 14.05 | 6.67% |
| #KMI | N/A | N/A | 0.54 | 2.57% |
| #KO | N/A | N/A | 5.73 | 8.59% |
| #KODK | N/A | N/A | -0.49 | -8.51% |
| #LMT | N/A | N/A | 26.68 | 4.93% |
| #MA | N/A | N/A | 18.68 | 4.02% |
| #MCD | N/A | N/A | 25.11 | 9.53% |
| #MLM | N/A | N/A | -55.64 | -9.44% |
| #MMM | N/A | N/A | 8.5 | 6.73% |
| #MO | N/A | N/A | 4.3 | 8.69% |
| #MS | N/A | N/A | 0.79 | 0.77% |
| #NIO | N/A | N/A | -0.24 | -5.61% |
| #NSC | N/A | N/A | 7.85 | 3.16% |
| #OXY | N/A | N/A | -3.23 | -5.37% |
| #PFE | N/A | N/A | -1.24 | -4.10% |
| #PG | N/A | N/A | 10.45 | 6.49% |
| #PM | N/A | N/A | 8 | 6.94% |
| #RNG | N/A | N/A | -1.28 | -3.71% |
| #RTX | N/A | N/A | 6.62 | 5.67% |
| #SLB | N/A | N/A | -3.5 | -7.37% |
| #SNOW | N/A | N/A | -13.68 | -10.73% |
| #SQ | N/A | N/A | 2.79 | 4.41% |
| #STZ | N/A | N/A | -5.06 | -2.06% |
| #T | N/A | N/A | 0.74 | 3.86% |
| #TAP | N/A | N/A | 1.08 | 2.05% |
| #TME | N/A | N/A | -3.5 | -25.18% |
| #TOT | N/A | N/A | 1.61 | 2.39% |
| #V | N/A | N/A | 11.28 | 4.26% |
| #VMC | N/A | N/A | -28.04 | -10.29% |
| #VZ | N/A | N/A | 1.46 | 3.62% |
| #WMT | N/A | N/A | 8.17 | 11.83% |
| #XOM | N/A | N/A | -0.75 | -0.63% |
| #NFLX | N/A | N/A | 58.67 | 9.14% |
| #NKE | N/A | N/A | N/A | N/A |
Interesting facts about the #JNJ (Johnson & Johnson)
Johnson & Johnson is a large manufacturing company with headquarters in New Jersey, USA. Most of the company's cash flows are provided by the production and sale of medicines. This division operates in five therapeutic areas, including immunology; vaccines, and infectious diseases; neurology; oncology; metabolic and cardiovascular diseases. The production of medical equipment also brings good income to the company.
Johnson & Johnson is the developer of a single-use COVID-19 vaccine, and the company also deals with robotic surgery. In 2019, the issuer acquired Auris Health because of its surgical robotic equipment. This enabled the company to expand its range of procedures and compete with leading companies in the field of surgical robotics.
J&J’s widely diversified portfolio of drugs and various products makes it possible for the company to mitigate the risk of falling J&J stocks. Even if a drug is disapproved by the FDA and other regulators, it will have minimal impact on the company.
Despite the upcoming end of the Covid-19 pandemic, people will likely continue to be vaccinated to maintain immunity to the disease. However, there is a risk. A large French study claimed the risk of hospitalization after being vaccinated with Johnson & Johnson's vaccine was about five times higher than after a shot of the Pfizer Inc or BioNTech SE vaccine. It means that Johnson & Johnson may lose significant funds.
Another risk is a potential spinoff. The market mildly reacted to the announcement made in November 2021 that the company might separate its consumer business into a new publicly-traded company by November 2023. However, there are risks that the reaction to a real spinoff will be stronger. Investors are unsure about the earning potential of both companies. Moreover, J&J has been dealing with many legal challenges over the past several years, which may result in additional fines and settlements.
Johnson & Johnson shares are listed on the New York Stock Exchange under the ticker #JNJ. A negative outcome of potential risks will lead to a fall in the stock’s price.
Technical & Fundamental Analysis and Forecast #JNJ (Johnson & Johnson)
10.06.2024 12:20
Will JNJ stock recover after the pandemic? Rean on to find out the future of Johnson & Johnson.
401430
Follow us in social networks!
Live Chat
Leave a feedback